Glaukos Free Cash Flow 2014-2024 | GKOS
Glaukos annual/quarterly free cash flow history and growth rate from 2014 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Glaukos free cash flow for the quarter ending September 30, 2024 was -66.35, a year-over-year.
- Glaukos free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.
- Glaukos annual free cash flow for 2023 was $-0.078B, a 23.43% increase from 2022.
- Glaukos annual free cash flow for 2022 was $-0.063B, a 173.89% increase from 2021.
- Glaukos annual free cash flow for 2021 was $-0.023B, a 22.89% decline from 2020.
| Glaukos Annual Free Cash Flow | |
|---|---|
| 2023 | -78.01 |
| 2022 | -63.20 |
| 2021 | -23.07 |
| 2020 | -29.92 |
| 2019 | -5.09 |
| 2018 | 8.55 |
| 2017 | 19.78 |
| 2016 | 6.03 |
| 2015 | -3.07 |
| 2014 | -7.98 |
| 2013 | -14.16 |
| Glaukos Quarterly Free Cash Flow | |
|---|---|
| 2024-09-30 | -66.35 |
| 2024-06-30 | -55.32 |
| 2024-03-31 | -34.84 |
| 2023-12-31 | -78.01 |
| 2023-09-30 | -63.13 |
| 2023-06-30 | -51.60 |
| 2023-03-31 | -37.67 |
| 2022-12-31 | -63.20 |
| 2022-09-30 | -50.90 |
| 2022-06-30 | -18.34 |
| 2022-03-31 | 3.23 |
| 2021-12-31 | -23.07 |
| 2021-09-30 | -9.10 |
| 2021-06-30 | -16.97 |
| 2021-03-31 | -13.00 |
| 2020-12-31 | -29.92 |
| 2020-09-30 | -38.38 |
| 2020-06-30 | -27.53 |
| 2020-03-31 | -13.88 |
| 2019-12-31 | -5.09 |
| 2019-09-30 | 0.29 |
| 2019-06-30 | 4.29 |
| 2019-03-31 | -0.44 |
| 2018-12-31 | 8.55 |
| 2018-09-30 | -1.00 |
| 2018-06-30 | -4.63 |
| 2018-03-31 | -7.70 |
| 2017-12-31 | 19.78 |
| 2017-09-30 | 9.18 |
| 2017-06-30 | 4.57 |
| 2017-03-31 | 1.57 |
| 2016-12-31 | 6.03 |
| 2016-09-30 | 4.80 |
| 2016-06-30 | 3.88 |
| 2016-03-31 | -1.31 |
| 2015-12-31 | -3.07 |
| 2015-09-30 | -2.12 |
| 2015-06-30 | -1.38 |
| 2015-03-31 | -1.25 |
| 2014-12-31 | -7.96 |
| 2014-09-30 | -6.19 |
| 2014-06-30 | -6.13 |
| 2014-03-31 | -4.85 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.447B | $0.315B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $212.123B | 97.31 |
| Thermo Fisher Scientific (TMO) | United States | $203.433B | 24.33 |
| Edwards Lifesciences (EW) | United States | $44.937B | 29.08 |
| Alcon (ALC) | Switzerland | $44.417B | 29.72 |
| IDEXX Laboratories (IDXX) | United States | $36.400B | 41.66 |
| DexCom (DXCM) | United States | $34.790B | 53.98 |
| IQVIA Holdings (IQV) | United States | $34.065B | 18.87 |
| Mettler-Toledo (MTD) | United States | $26.604B | 30.90 |
| Waters (WAT) | United States | $21.953B | 31.15 |
| STERIS (STE) | Ireland | $21.550B | 24.65 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.044B | 0.00 |
| Hologic (HOLX) | United States | $14.190B | 15.31 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.755B | 14.12 |
| Globus Medical (GMED) | United States | $11.429B | 28.94 |
| Sysmex ADR (SSMXY) | Japan | $11.267B | 35.33 |
| Penumbra (PEN) | United States | $10.311B | 101.00 |
| Masimo (MASI) | United States | $9.707B | 46.97 |
| Teleflex (TFX) | United States | $7.776B | 12.40 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.679B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.528B | 0.00 |
| Veracyte (VCYT) | United States | $3.186B | 95.61 |
| Nihon Kohden (NHNKY) | Japan | $2.705B | 14.78 |
| LivaNova (LIVN) | United Kingdom | $2.589B | 14.95 |
| TransMedics (TMDX) | United States | $2.422B | 76.79 |
| Elekta AB (EKTAY) | Sweden | $2.392B | 21.50 |
| Tandem Diabetes Care (TNDM) | United States | $2.198B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.866B | 9.75 |
| Alphatec Holdings (ATEC) | United States | $1.523B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.291B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 83.50 |
| RxSight (RXST) | United States | $1.201B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.935B | 0.00 |
| AxoGen (AXGN) | United States | $0.798B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.792B | 17.31 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.762B | 12.94 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.711B | 0.00 |
| IRadimed (IRMD) | United States | $0.700B | 36.82 |
| SiBone (SIBN) | United States | $0.687B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.628B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.521B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.505B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.460B | 24.23 |
| AngioDynamics (ANGO) | United States | $0.418B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.416B | 22.51 |
| NeuroPace (NPCE) | United States | $0.367B | 0.00 |
| CVRx (CVRX) | United States | $0.366B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.287B | 0.00 |
| Inogen (INGN) | United States | $0.253B | 0.00 |
| Accuray (ARAY) | United States | $0.229B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.220B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.132B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.127B | 0.00 |
| LENSAR (LNSR) | United States | $0.122B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.090B | 13.77 |
| Vicarious Surgical (RBOT) | United States | $0.089B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.085B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 30.14 |
| Microbot Medical (MBOT) | United States | $0.057B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.039B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |